Navigation Links
Brain stent offers alternative to shunt for fixing potentially blinding vein narrowing
Date:3/13/2013

A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain.

The Johns Hopkins team's latest study, to be published in the Journal of Neuro-Ophthalmology online March 14, is believed to be the first to show how directly lowering pressure inside the vein alleviates the condition and improves vision.

The study report on 12 patients describes the team's novel use of intravascular ultrasound imaging to delicately thread an expandable metal stent, roughly two inches long and attached to a catheter, through an opening in the groin, all the way to the main blood vessels in the neck and shoulders draining fluid from the brain. The goal is to precisely position the stent across the narrowed portion of the vein, called the transverse sinus, where it expands, allowing blood to drain more freely and relieving fluid pressure in the brain. The vein narrowing, or stenosis, is considered to be the leading cause of pseudotumor cerebri. The condition earned its name, which translates to "false" tumor of the brain, because in the era before detailed brain imaging became available, surgeons used to operate on people with similar optic nerve swelling, suspecting brain tumors, yet they would find none.

Because the transverse sinus drains cerebrospinal fluid, constriction of the vessel causes fluid backup and raises intracranial pressure, which, if left untreated, can lead to permanent damage to the optic nerve, blurred vision and eventual blindness. Traditional treatments include drugs that reduce pressure and the surgical placement of a straw-like shunt between the lower spine and brain, or between the lower spine and stomach cavity to drain excess.

According to lead study investigator a
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medicine
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Certain Men May Face Higher Risk of Brain Injury
2. Bradley Hospital researchers find age-related changes in how autism affects the brain
3. Voices Against Brain Cancer Commends a Surgical Innovation That Lights Up Brain Tumors
4. Brain Imaging Detects Tiny Lesions Related to Mild Injury: Study
5. Neural synchrony may be key to understanding how the human brain perceives
6. Low T3 syndrome predicts unfavorable outcomes in surgical patients with brain tumor
7. Single Concussion May Lead to Lasting Brain Damage
8. Single concussion may cause lasting brain damage
9. Does Chewing Gum Give Your Brain an Edge?
10. Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimer’s Treatment
11. Human Brain Cells Used to Make Mice Smarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... ... and speaker lineup for its 2015 Annual Conference , the premiere ... 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... exclusively to healthcare providers, has been retained to lead a national chief ... of the top-ranked executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... ... 03, 2015 , ... Every year, One-to-1 Fitness and the Red Deer ... the Red Deer community with free fitness training and indoor fitness boot camp classes ... and entertainment raised thousands of charity dollars and ended with a $10,000 donation to ...
(Date:7/2/2015)... ... 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... located in the Lone Star State. The premium frozen yogurt chain was listed as ... store, which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... possible to stop tumor growth without harmful therapies, study ... research is moving scientists closer to their goal of ... tissue. , The researchers, who were scheduled to ... Clinical Congress, Oct. 11-15 in Chicago, have created a ...
... Without Relief , WASHINGTON, Oct. 14 Despite ... to raise taxes on the middle class, the House of ... process -- adopting provisions approved yesterday by the Senate Finance ... accounts (FSAs) in order to help pay for health care ...
... PARK, Calif., Oct. 14 New Enterprise Associates, Inc. (NEA), ... Viswanathan, PhD, has been promoted to General Partner. Dr. Viswanathan, ... and growth equity information technology investments, as well as the ... MD, to Principal. Dr. Torti joined NEA in 2007 and ...
... Networks , the nation,s leading provider of physician office-based ... consumer purchase behavior, not just purchase intent, for OTC ... revenue and justify investments designed to capture market share, ... health messages to purchase volume. To address this need ...
... study of over 3,000 adults aged 70-79, the apparent ... functional decline over time did not hold up after ... particular physical activity, body weight, education, and income. ... the Journal of the American Geriatrics Society , ...
... 14 Cardium Therapeutics (NYSE Amex: CXM ) ... clinical trial of Excellarate(TM) for the potential treatment of ... the Company,s Gene Activated Matrix (GAM) technology platform. ... candidate (GAM501, which is a combination of Ad5PDGF-B and ...
Cached Medicine News:Health News:Stem Cells Being Tested to Fight Pancreatic Cancer 2Health News:Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 2Health News:Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 3Health News:NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 2Health News:NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 3Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 3Health News:'Beneficial' effects of alcohol? 2Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 2Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 3Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 4Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 5Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 6Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 7Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 8Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 9Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 10Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 11Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 12Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 13Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 14
(Date:7/2/2015)... BGI gab heute bekannt, dass ... American College of Pathologists (CAP) akkreditiert wurde. ... klinische Next-Generation-Sequencing Labor, das in ... somit die höchsten Standards an klinischer Laborpraxis ... - 21 CFR Part 11 konformen Laborverfahren ...
(Date:7/2/2015)... , July 2, 2015  AbbVie (NYSE: ... on Friday, July 24, 2015, before the market opens. ... the earnings conference call at 8 a.m. Central time ... Investor Relations website at www.abbvieinvestor.com . An archived ... a.m. Central time. About AbbVie ...
(Date:7/2/2015)... June 25, 2015 Research ... the "Veterinary / Animal Vaccines Market by Product, ... report to their offering. The global animal ... 2020 from $5,507.3 Million in 2015, at a CAGR ... factors fueling market growth are growing prevalence of animal ...
Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2
... 2011 BD Biosciences, a segment of BD (Becton, ... new BD Falcon™ Multi-Flask, a multi-layer cell culture device ... easily and more efficiently. Currently, most ... new BD Falcon Multi-Flask, available in both three- and ...
... Thousands of jobs in Texas supported by the biopharmaceutical ... such as imposing new taxes in the Medicare prescription ... From research to technical work, manufacturing to construction ... services, the biopharmaceutical sector supports a broad array of ...
Cached Medicine Technology:BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 3
... Riata i lead family ... versatility when managing patients ... (DFTs)., The new Riata ... physicians even more versatility ...
... Millennium™ microsurgical system delivers on the ... technology. For the latest advancement in ... Bausch & Lomb Surgical offers CONCENTRIX™ ... pump to provide both flow and ...
... Microscope with excellent maneuverability. Konan ... weight maintaining high quality. Easy ... by simply changing the adapter. ... has resulted in a sharp ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
Medicine Products: